Share this article
Share this article
ResearchAndMarkets.com s offering.
The medical device industry has unique challenges and opportunities. During 2020, many of these challenges, and opportunities, were highlighted even more so. It is a heavily regulated industry in most nations of the world. Devices need to be approved for reimbursement and prices are negotiated in many cases by group purchasing organizations and governments. Companies in the field must make constant research and development investments to produce the innovations that drive market success. Yet, despite these challenges, devices also benefit from servicing an enlarging elderly population around the world. Devices are also among the first priority of emerging market nations, as they increase the size of their economies and their healthcare spending. Therefore, there are a great many device competitors and continued investors and venture capital interested in the field.
Electronic Reportable Laboratory Result Reporting. Requiring hospitals to report these four measures would help to prepare public health agencies to respond to future health threats and a long-term COVID-19 recovery by strengthening public health functions, including early warning surveillance, case surveillance and vaccine uptake, which will increase the information available to help hospitals better serve their patients, said CMS officials.
The new requirements would enable nationwide syndromic surveillance that could help provide early notices of emerging disease outbreaks, according to CMS.
Additionally, automated case and lab reporting would speed response times for public health agencies, while broader and more granular visibility into immunization uptake patterns would help these agencies tailor their vaccine distribution plans.